Helicobacter pylori Treatment Methods
Helicobacter pylori is a spiral-shaped, microaerophilic bacterium with extremely stringent growth requirements. It is currently the only known microbial species capable of colonizing the human stomach. Infection with H. pylori is associated with gastritis, gastric ulcers, and even gastric cancer. Common symptoms following infection include upper abdominal discomfort, acid reflux, belching, abdominal pain, and abdominal distension.
Eradication therapy is generally recommended for H. pylori infection. The current standard treatment is quadruple therapy, which consists of one proton pump inhibitor (PPI), two antibiotics, and one bismuth compound, administered for 10–14 days. This regimen represents the established standard of care for H. pylori eradication.
The choice of a specific quadruple therapy regimen should be individualized based on the patient’s history of drug allergies, hepatic and renal function, and prior treatment experiences. A follow-up test—typically performed approximately four weeks after completing therapy—is used to confirm eradication; a negative result is generally considered indicative of successful eradication.